GoodRx Care vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit TrimRx - our featured pick→or find your match

Novi beats GoodRx Care overall, scoring 7.8/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $133/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at GoodRx Care and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

GoodRx Care

#48 of 53

6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care

Higher Rated

Novi

#12 of 53

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Feature	GoodRx Care	Novi
Our Score	6.2/10	7.8/10
Starting Price	$119/mo	$133/mo
Medication Type	Brand	Compounded
Insurance Accepted	Yes	No
Best For	Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing, $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill	Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out for	Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms	Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking	#48	#12
Get started	Visit GoodRx Care	Visit Novi

Pros & Cons Compared

GoodRx Care

Pros

+2026 subscription rewrite, $119/mo standard membership with medication priced among the lowest on the market
+Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
+Oral Wegovy pill available at $149-199/mo, one of the cheapest oral semaglutide routes
+Insurance accepted, GoodRx's integration with savings cards can stack with coverage

Cons

−Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms
−Compounded GLP-1s are de-emphasized on current marketing, may no longer be available
−Subscription model means ongoing monthly fee even in maintenance months
−Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Novi

Pros

+Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
+Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
+Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
+Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
+Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
+100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
−Founding year, headquarters city, and corporate ownership are not publicly disclosed
−Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
−Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

Novi edges out GoodRx Care with a score of 7.8/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Novi's $133/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing, $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither GoodRx Care nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review